scholarly journals Conducting clinical trials in emerging markets of sub-Saharan Africa: review of guidelines and resources for foreign sponsors

Author(s):  
Gaurav Puppalwar ◽  
Meenakshi Mourya ◽  
Ganesh Kadhe ◽  
Amey Mane
Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Neema Toto ◽  
Elaine Douglas ◽  
Markus Gmeiner ◽  
Lynn K. Barrett ◽  
Robert Lindblad ◽  
...  

Author(s):  
Khali Mofuoa

In African emerging markets (AEMs), the prevailing notions of social responsibility (SR) are based chiefly on Western ethics. Even discussions of corporate social responsibility (CSR) have, more often than not, been couched in the similar manner. Consequently, the field of CSR in AEMs is largely unaware of Setho ethics that for it are germane as a basis for thinking and talking about SR. In this chapter, the author proposes Setho ethics rooted in Botho, which sees the communal, interdependence and interrelatedness of beings, as an alternative vision of CSR in AEMs. In fact, people in Sub-Saharan Africa (SSA) see themselves in a symbiotic relationship with society, a point well-articulated by Mbiti (1969, p. 24) thus, “I am because you are, and since we are, therefore I am”. This African view through the Setho ethics lenses generates a different notion of an ideal SR of business to society worth illuminating in the CSR discourse today.


Author(s):  
Umar Mohammed

Africa is one of the fastest growing regions on the globe and is home to seven of the ten fastest growing markets in the world. Sub-Saharan Africa in particular has many natural resources which has made it a hub for international trade. Turkey's search for alternative market to accelerate the development of its emerging markets has led to its economic engagement in sub-Saharan Africa. However, much has not been written on Turkey's inroads in that part of the continent. Therefore, the purpose of this paper is to review the progress of Turkey's trade and investment in sub Saharan Africa. It indicates that Turkey in the past didn't have much economic relationships with Sub Saharan Africa as compared to Northern Africa. Whilst the volume of Turkey's trade and investment in Sub- Saharan Africa keeps uprising, there are some limitations and difficulties to this partnership such as informational gap on both sides.


Author(s):  
Morenike Oluwatoyin Folayan ◽  
Brandon Brown ◽  
Bridget Haire ◽  
Chinedum Peace Babalola ◽  
Nicaise Ndembi

JAMA ◽  
2004 ◽  
Vol 292 (2) ◽  
pp. 237 ◽  
Author(s):  
David M. Kent ◽  
D. Mkaya Mwamburi ◽  
Michael L. Bennish ◽  
Bruce Kupelnick ◽  
John P. A. Ioannidis

PLoS ONE ◽  
2017 ◽  
Vol 12 (3) ◽  
pp. e0173796 ◽  
Author(s):  
Nerina Vischer ◽  
Constanze Pfeiffer ◽  
Manuela Limacher ◽  
Christian Burri

2013 ◽  
Vol 10 (10) ◽  
pp. 599-604 ◽  
Author(s):  
Trijn Israëls ◽  
Joyce Kambugu ◽  
Francine Kouya ◽  
Nader Kim El-Mallawany ◽  
Peter B. Hesseling ◽  
...  

2021 ◽  
pp. 1358-1363
Author(s):  
Abiola Ibraheem ◽  
Colin Pillai ◽  
Ifeoma Okoye ◽  
J. Joshua Smith ◽  
Diane Reidy-Lagunes ◽  
...  

Cancer is now a formidable health care burden in sub-Saharan Africa (SSA) due to lifestyle westernization and longer life expectancy. The exponential increase in cancer incidence coupled with high mortality rate is not comparable with that seen in westernized countries. To address global cancer disparity, globalization of cancer clinical trials to involve sub-Saharan Africa can serve as a platform where innovative targeted therapies can be made available to patients in the environ. In the 2019 African Organization for Research and Training in Cancer (AORTIC) conference held at Maputo, Mozambique, a group of clinical trialists spanning across multiple continents highlighted the opportunities in Africa for the conduct of cancer clinical trials. The secondary purpose of the meeting was to address the belief that Africa was incapable of conducting interventional cancer trials but showed the in-continent strengths, such as available capacities, trained local clinical trialists with clinical trial experiences, clinical trial consortia, local capabilities, mapping out logistics, ethical consideration, political will, real-time benefits of clinical trials to clinical practice, and future directions for trials.


Sign in / Sign up

Export Citation Format

Share Document